Keith R. Fandrick
CIK: 0002159394
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
IRLA
IRulya Therapeutics Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Fandrick Keith R.
Fandrick Keith R. (SEC CIK 0002159394) files insider reports with the SEC as Chief Operating Officer of IRulya Therapeutics Inc. (IRLA).
Signal8 holds 1 ownership filing by Fandrick Keith R., a Form 3, filed on Oct 19, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Fandrick Keith R.'s filings is in NEW HAVEN, CT.
Other insiders filing for IRulya Therapeutics Inc. (IRLA)
- Bonuccelli Catherine M., Director
- Valentine James Elwood, Director
- Wise John Drayton, Director
- Militello John, Chief Financial Officer
- PATTERSON LEONE D, Director